Eli Lilly announced it has initiated legal action against several wellness vendors. The company aims to combat unauthorized sales of its experimental weight-loss drug, retatrutide. By filing six lawsuits, Eli Lilly seeks to address the surge in illegal online sales.
Retatrutide is currently in the experimental phase and has not been approved for general use. Despite this, some vendors have been distributing unauthorized versions of the drug. The company’s legal efforts are part of a broader strategy to prevent the misuse of its products.
The company stressed the importance of ensuring that medications are used safely and legally. They reiterated their commitment to taking necessary legal steps to protect consumers and maintain the integrity of their research.
Leave a Reply